To explore whether olivomycin A exhibits anticancer activities against kidney cancer cells and the potential impact of p53 in the system, we employed two human renal cell carcinoma cell lines: A-498 cells, which carry wild-type p53, and 786-O cells, which harbor mutant p53 and PTEN genes. This evidence concerns the gene TP53 and renal cell carcinoma.